Home > Boards > US Listed > Medical - Drugs > Provectus Biopharmaceuticals Inc. (PVCT)

new blog post

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
buccaneer1961 Member Profile
Member Level 
Followed By 293
Posts 43,480
Boards Moderated 16
Alias Born 02/24/10
160x600 placeholder
Provectus Biopharmaceuticals’ PV-10 Clinical Data on the Treatment of Melanoma to Be Presented at European Society for Medi... "Business Wire" - 7/23/2014 9:13:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/23/2014 6:06:15 AM
Glancy Binkow & Goldberg LLP Reminds Investors of the Lead Plaintiff Deadline in the Class Action Lawsuit Aga... "Business Wire" - 7/15/2014 8:32:00 AM
Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Provectu... "Business Wire" - 7/8/2014 4:14:00 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 7/8/2014 2:39:27 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/8/2014 6:06:30 AM
Provectus Updates Shareholders in Its Annual CEO Letter "Business Wire" - 7/8/2014 6:00:00 AM
Shareholder Rights Law Firm Johnson & Weaver, LLP Reminds Investors of Provectus Biopharmaceuticals, Inc. ... "Business Wire" - 7/3/2014 10:34:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 7/1/2014 10:23:05 AM
Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and ... "PR Newswire (US)" - 6/27/2014 1:58:00 PM
Class Action Lawsuit Against Provectus Biopharmaceuticals, Inc. Announced by Glancy Binkow & Goldberg LLP "Business Wire" - 6/26/2014 10:32:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/19/2014 6:02:46 AM
Provectus Biopharmaceuticals, Inc. to Hold Conference Call Today to Detail Outline of Phase 3 Clinical Trial of PV-10 in Mela... "Business Wire" - 6/19/2014 6:00:00 AM
Cohen Milstein Sellers & Toll PLLC Announces the Investigation of Provectus Biopharmaceuticals, Inc. "Business Wire" - 6/18/2014 5:42:00 PM
Class Action Lawsuit Against Provectus Biopharmaceuticals, Inc. Announced by Law Offices of Howard G. Smith "Business Wire" - 6/17/2014 10:32:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/17/2014 6:06:29 AM
Pittsburgh Law Office of Alfred G. Yates Jr., P.C. Files Class Action Lawsuit On Behalf of Shareholders of Provectus Biopharm... "PR Newswire (US)" - 6/16/2014 4:18:00 PM
Lifshitz & Miller Law Firm Announces Investigation of Annie's, Inc., Montage Technology Group Limited, OpenTable, Inc., Prove... "PR Newswire (US)" - 6/14/2014 10:01:00 AM
Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In Provectus Biopharmaceuticals... "PR Newswire (US)" - 6/14/2014 9:32:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/12/2014 6:04:25 AM
Provectus Biopharmaceuticals to Discuss Outline of Phase 3 Clinical Trial Of PV-10 To Treat Melanoma on Conference Call "Business Wire" - 6/12/2014 6:00:00 AM
Brower Piven Encourages Investors With Losses Over $100,000 In Provectus Biopharmaceuticals, Inc. To Conta... "Business Wire" - 6/6/2014 3:10:00 PM
Investigation on Behalf of Provectus Biopharmaceuticals, Inc. Investors Announced by Law Offices of Howard... "Business Wire" - 6/3/2014 5:32:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/3/2014 8:22:22 AM
PV-10 Data Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting Defines Path Forward for Provectus Bi... "Business Wire" - 6/3/2014 8:22:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist